Wenxing Qin

1.1k total citations
30 papers, 780 citations indexed

About

Wenxing Qin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wenxing Qin has authored 30 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Wenxing Qin's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Wenxing Qin is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Wenxing Qin collaborates with scholars based in China, United States and France. Wenxing Qin's co-authors include Yongyi Huang, Te Liu, Jiejun Wang, Huiying Chi, Jiulin Chen, Chuan Chen, Jian Zhang, Zhihua Yu, Te Liu and Qi Feng and has published in prestigious journals such as SHILAP Revista de lepidopterología, FEBS Letters and International Journal of Cancer.

In The Last Decade

Wenxing Qin

29 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenxing Qin China 17 437 283 171 126 95 30 780
Yun Hee Kang South Korea 18 535 1.2× 212 0.7× 332 1.9× 75 0.6× 115 1.2× 44 1.0k
Jinah Park South Korea 19 787 1.8× 185 0.7× 262 1.5× 25 0.2× 137 1.4× 32 1.1k
Preeti Shah United States 15 512 1.2× 228 0.8× 335 2.0× 34 0.3× 226 2.4× 30 827
Roberto A. Leon‐Ferre United States 15 275 0.6× 284 1.0× 447 2.6× 146 1.2× 176 1.9× 53 989
Silvia Rita Vitale Italy 16 429 1.0× 333 1.2× 251 1.5× 35 0.3× 182 1.9× 46 978
Monika Świerczewska Poland 16 340 0.8× 228 0.8× 345 2.0× 28 0.2× 121 1.3× 31 712
Sujatha Jagadeeswaran United States 12 465 1.1× 197 0.7× 360 2.1× 17 0.1× 169 1.8× 16 973
Minshu Yu United States 20 541 1.2× 155 0.5× 516 3.0× 53 0.4× 77 0.8× 37 959
Wenwen Chien United States 20 822 1.9× 212 0.7× 250 1.5× 22 0.2× 104 1.1× 29 1.1k
Andrea Ghelli Luserna di Rorà Italy 13 513 1.2× 98 0.3× 303 1.8× 54 0.4× 64 0.7× 38 735

Countries citing papers authored by Wenxing Qin

Since Specialization
Citations

This map shows the geographic impact of Wenxing Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxing Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxing Qin more than expected).

Fields of papers citing papers by Wenxing Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenxing Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxing Qin. The network helps show where Wenxing Qin may publish in the future.

Co-authorship network of co-authors of Wenxing Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Wenxing Qin. A scholar is included among the top collaborators of Wenxing Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxing Qin. Wenxing Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qin, Bao‐Dong, Xiao‐Dong Jiao, Zhan Wang, et al.. (2023). Pan‐cancer efficacy and safety of anlotinib plus PD ‐1 inhibitor in refractory solid tumor: A single‐arm, open‐label, phase II trial. International Journal of Cancer. 153(4). 815–825. 9 indexed citations
3.
4.
Wang, Lan, Lan Zhu, Wenxing Qin, et al.. (2023). CT-Based Radiomic Score: A Risk Stratifier in Far-Advanced Gastric Cancer Patients. Academic Radiology. 30. S220–S229. 7 indexed citations
5.
Feng, Qi, Wenxing Qin, Yao Zhang, et al.. (2021). Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 17 indexed citations
6.
7.
Feng, Qi, Xiaojing Du, Zhiying Zhao, et al.. (2021). Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 729340–729340. 22 indexed citations
8.
Qin, Bao‐Dong, Xiao‐Dong Jiao, Ke Liu, et al.. (2019). Basket Trials for Intractable Cancer. Frontiers in Oncology. 9. 229–229. 21 indexed citations
9.
10.
Han, Jun, Wenxing Qin, Hao Xing, et al.. (2018). Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Clinica Chimica Acta. 488. 68–75. 40 indexed citations
11.
Qin, Wenxing, et al.. (2018). DC‐CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1‐ASK1‐AIP1 pathway to kill autologous ovarian cancer stem cells. Journal of Cellular and Molecular Medicine. 22(7). 3364–3376. 21 indexed citations
12.
Li, Chao, Jin Zhang, Jun Han, et al.. (2018). High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival. Cellular Physiology and Biochemistry. 51(6). 2829–2842. 20 indexed citations
13.
Qin, Bao‐Dong, Xiao‐Dong Jiao, Ke Liu, et al.. (2018). The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review. OncoTargets and Therapy. Volume 11. 4739–4745. 25 indexed citations
14.
Jiao, Xiao‐Dong, et al.. (2016). Paralytic ileus due to a novel anticancer drug, nab-paclitaxel: A case report. Molecular and Clinical Oncology. 4(5). 824–826.
15.
Qin, Wenxing, et al.. (2016). Protein arginine methyltransferase 1 interacts with Gli1 and regulates its transcriptional activity. Tumor Biology. 37(7). 9071–9076. 7 indexed citations
16.
Lv, Cuiting, Wenxing Qin, Tonghan Zhu, et al.. (2015). Ophiobolin O Isolated from Aspergillus ustus Induces G1 Arrest of MCF-7 Cells through Interaction with AKT/GSK3β/Cyclin D1 Signaling. Marine Drugs. 13(1). 431–443. 23 indexed citations
17.
Liu, Te, Yongyi Huang, Jian Zhang, et al.. (2014). Transplantation of Human Menstrual Blood Stem Cells to Treat Premature Ovarian Failure in Mouse Model. Stem Cells and Development. 23(13). 1548–1557. 146 indexed citations
18.
19.
Liu, Te, Wenxing Qin, Yongyi Huang, Yan Zha, & Jiejun Wang. (2013). Induction of Estrogen-Sensitive Epithelial Cells Derived from Human-Induced Pluripotent Stem Cells to Repair Ovarian Function in a Chemotherapy-Induced Mouse Model of Premature Ovarian Failure. DNA and Cell Biology. 32(12). 685–698. 40 indexed citations
20.
Qin, Wenxing, et al.. (2013). MicroRNA‐155 is a novel suppressor of ovarian cancer‐initiating cells that targets CLDN1. FEBS Letters. 587(9). 1434–1439. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yun Hee Kang Breakdown of academic impact, for papers by Jinah Park Breakdown of academic impact, for papers by Preeti Shah Breakdown of academic impact, for papers by Roberto A. Leon‐Ferre Breakdown of academic impact, for papers by Silvia Rita Vitale Breakdown of academic impact, for papers by Monika Świerczewska Breakdown of academic impact, for papers by Sujatha Jagadeeswaran Breakdown of academic impact, for papers by Minshu Yu Breakdown of academic impact, for papers by Wenwen Chien Breakdown of academic impact, for papers by Andrea Ghelli Luserna di Rorà
Rankless by CCL
2026